Breast and ovarian surgery reduces cancer risk in women at high riskBMJ 2022; 376 doi: https://doi.org/10.1136/bmj.o258 (Published 15 February 2022) Cite this as: BMJ 2022;376:o258
- Helen Saul, editor in chief1,
- Deniz Gursul, research dissemination officer1,
- Samantha Cassidy, science writer1,
- Gareth Evans, professor of medical genetics2
- 1NIHR Centre for Engagement and Dissemination, Twickenham, UK
- 2University of Manchester, Manchester, UK
- Correspondence to H Saul
Marcinkute R, Woodward ER, Gandhi A, et al. Uptake and efficacy of bilateral risk reducing surgery in unaffected female BRCA1 and BRCA2 carriers. J Med Genet 2021;0:1-8.
To read the full NIHR Alert, go to: https://evidence.nihr.ac.uk/alert/earlier-decisions-breast-ovarian-surgery-reduce-risk-cancer/
Competing interests: The BMJ has judged that there are no disqualifying financial ties to commercial companies. The authors declare the following other interests: none.
Further details of The BMJ policy on financial interests is here: https://www.bmj.com/about-bmj/resources-authors/forms-policies-and-checklists/declaration-competing-interests.
All authors contributed to development and review of this summary, as part of the wider NIHR Alerts editorial team.
Disclaimer: NIHR Alerts are owned by the Department of Health and Social Care and are made available to The BMJ under licence. NIHR Alerts report and comment on health and social care research but do not offer any endorsement of the research. The NIHR assumes no responsibility or liability arising from any error or omission or from the use of any information contained in NIHR Alerts.
Permission to reuse these articles should be directed to NIHRAlerts@nihr.ac.uk